Deep Intelligence Across Industries

Company Headquarter: Northern New Jersey (US) Founded: 2008 Workforce: 50 employees Company Working: Extremity Medical LLC is involved in developing orthopedic devices. The company develops advanced products used by surgeons for treating patients having problems in ankle, wrist, feet, and hands. The company is focused on recognizing unmet requirements and evolving solutions for fixation, fusion, and motion preserving systems for lower and upper extremities.

Company Headquarter: New York, US Founded: 2005 Workforce: 155+ employees Company Working: Synergy Pharmaceuticals Inc. is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies. The company holds 100% worldwide rights to the proprietary uroguanylin based GI platform that includes one commercial product, TRULANCE (plecanatide), and a second lead product candidate, dolcanatide.

Company Headquarters: Taizhou, Zhejiang Founded: 1974 Company Working: Zhejiang Yongning Pharmaceutical is a pharmaceutical company that is engaged in manufacturing and marketing of a wide range of innovative medicines and pharmaceutical APIs in China. It is one of the national high-tech companies in the Zhejiang province. It develops and sells antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health care drugs, and other related products.

Company Headquarters: New Jersey, US Workforce: ~35 Company Working: Best Naturals manufactures the highest-quality nutritional supplements, in accordance with industry standards at an affordable price range. The company develops vitamins and dietary supplements. Best Naturals is a highly-trusted brand with products that ensure nutritional support to its customers. The company’s products are manufactured in a cGMP compliant environment.

Company Headquarters: India Founded: 2008 Company Working: Chiral Bio Sciences Ltd (Chiral) is one of the fastest growing companies in the area of synthetic technology and chiral compounds. The company harnesses a combination of extensive expertise and latest technology and offers quality products and solutions that are innovative and cost-effective, catering to the rigorous and wide-ranging requirements of customers in the industry. Chiral embodies the vision of a top-notch player in developing and commercializing products catering to a variety of therapeutic categories. It currently manufactures advanced drug intermediates for Anti Retro Virals, Anti-Hypertensive, Anti Diabetic, etc. Chiral presently has an R&D Center with attached pilot plant and two commercial production units, totaling 80 KL capacity. It follows and maintains good manufacturing practices. A state-of-the-art manufacturing unit consisting of two production blocks of 80 KL each, meets all the international regulatory requirements that have been set up. The R&D Center is also scaled up to high levels/standards

Company Headquarters: China Founded: 2005 Company Working: Afine Chemicals Ltd (Afine) specializes in fine chemicals and pharmaceuticals. Its products have earned great popularity in world markets. Since 2005, the company had been rapidly growing to become a leading manufacturer and trader of APIs in China. Afine has set up two independent business divisions, namely, fine chemicals division and pharmaceutical division. Afine’s chemical department is involved in manufacturing and trading of a variety of high-quality optical brightener and textile auxiliary as well as dyestuff, pigments, and other fine chemicals. The company is one of the leading exporters of optical brightener in China. The pharmaceutical division is involved in manufacturing, contract R&D, marketing and distribution of active pharmaceutical ingredients, intermediates, and feed additives. In March 2009, the Hangzhou government awarded “Top 100 innovation-oriented export enterprises of Hangzhou in 2008” among more than 13,000 export enterprise of Hangzhou

Company Headquarters: India Founded: 1998 Company Working: Jigs Chemicals is an innovative sourcing and distribution company. It is involved in both exclusive representation and global supply of a wide range of quality API and intermediates. Along with its core pharmaceutical business in India, the company is an integrated supplier of industrial chemicals with a strong presence across the globe. It has created a customized and unique team with 20 years of experience. It fulfills its customers' requirements with the highest quality products according to client timelines, specifications, and regulatory requirements. It specializes in providing complete sourcing options. Jigs Chemicals works closely with top international pharmaceutical producers (ISO and cGMP certification, US-FDA approvals, etc.). It provides its clients with excellent technical and regulatory support (COS/CEP, E-DMF/CTD or US-DMF) for all products.

Company Headquarters: South Korea Founded: 1983 Company Working: Daewoong Bio Inc. operates as full service a pharmaceutical company, across the globe. It develops, produces, and markets antibiotics and active pharmaceutical ingredients, such as bile acids and carbapenems. These products are used for the treatment for burns, pressure ulcers, diabetic foot ulcers, and others. The company’s bone healing products include products for surgical treatment of the spine & orthopedics and biomaterials, such as bone substitutes and bioresorbable.

Company Headquarter: Shanghai, China Founded: 2014 Workforce: ~200 Company Working: CARsgen Therapeutics (CARsgen) is a clinical-stage immune-oncology company focused on the development of CAR-T therapeutics. The company primarily operates in China and the US. The company has established a broad pipeline of CAR-T product candidates covering several solid and blood tumors in areas of significant unmet medical needs. The company launched several clinical trials for the treatment of relapsed/refractory tumors, including CAR-GPC3-T trial for hepatocellular carcinoma (HCC) and squamous lung cancer, CAR-EGFR/EGFRvIII-T trial for glioblastoma, and CAR-Claudin18.2-T for gastric and pancreatic cancer. CARsgen also has ongoing clinical programs with a humanized CAR-CD19-T trial for leukemia and a fully human CAR-BCMA-T trial for multiple myeloma. CARsgen intends to submit five investigational new drugs (IND) to the National Medical Products Administration (NMPA), China, and 2 INDs to the FDA in 2019.